Our medical expertise includes: Medical Director of clinical laboratory services, microbiology and infectious disease specialist, oncologists, pathologists, and molecular biologist each with more than 25 years’ experience.   

Our corporate expertise includes:

  • Patenting proprietary intellectual properties 
  • Development of new test panels within 4-6 weeks
  • Patented and proprietary Quality Control protocols
  • Commissioning of clinical laboratories (CLIA/CAP)
  • Test validation with medical centers of excellence
  • Testing and reporting patient samples 
  • Recipient of Medicare and third-party payments for routine testing. 
  • Presentations at US and international medical conferences
  • Peer reviewed publications
  • FDA submission 
  • First to develop a molecular test to detect SARS-CoA (2003)
  • First to develop DNA sequencing test panel for SARS-CoA, MERS-CoA and COVID-19